Latest Breaking News On - Michael landsittel - Page 2 : comparemela.com

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168 00

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealand generalNew zealandMichael landsittelJeffreyw albersPiper sandlerNeedham companyBlueprint medicines corporationBlueprint medicines company profileSecurities exchange commissionPolar capital holdings plcVanguard group incGoldman sachs groupWellington management groupBlueprint medicinesFree report

Blueprint Medicines Co (NASDAQ:BPMC) CFO Sells $1,050,000 00 in Stock

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) CFO Michael Landsittel sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $105.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 47,286 shares of […]

United statesMichael landsittelBlueprint medicines company profilePolar capital holdings plcBlueprint medicines coNorges bankGoldman sachs groupNeedham companyBlueprint medicines corporationBlueprint medicinesGet free reportMedicines stock downCapital holdings plcSprings capital managementPartners managementMedicines corporation

Blueprint Medicines (BPMC) Buy Rating Reaffirmed at Needham & Company LLC

Blueprint Medicines (BPMC) Buy Rating Reaffirmed at Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMichael landsittelStifel nicolausJeffreyw albersBlueprint medicines corporationNeedham companyChina universal asset management coCutler groupCompass wealth managementFinancial services group incAssociates corpSecurities exchange commissionBlueprint medicinesFree reportGet free reportDirector jeffrey

Blueprint Medicines (NASDAQ:BPMC) Earns Buy Rating from HC Wainwright

Blueprint Medicines (NASDAQ:BPMC) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesChristopherk murrayStifel nicolausMichael landsittelPolar capital holdings plcNeedham companySecurities exchange commissionBlueprint medicines corporationNorges bankBlueprint medicinesGet free reportMedicines stock downExchange commissionCapital holdings plcSprings capital managementPartners management

Blueprint Medicines Co (NASDAQ:BPMC) Given Consensus Recommendation of Moderate Buy by Brokerages

Blueprint Medicines Co (NASDAQ:BPMC) Given Consensus Recommendation of Moderate Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesKate havilandMichael landsittelVanguard group incWells fargo companyRafferty asset managementAmerican century companies incChina universal asset management coNeedham companyBlueprint medicines coSecurities exchange commissionBlueprint medicines corporationBlueprint medicinesGet free reportExchange commissionCentury companies